Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.56
+0.01 (0.15%)
At close: Nov 3, 2025, 4:00 PM EST
6.50
-0.06 (-0.91%)
After-hours: Nov 3, 2025, 4:11 PM EST
Bioventus Market Cap
Bioventus has a market cap or net worth of $438.81 million as of November 3, 2025. Its market cap has decreased by -47.90% in one year.
Market Cap
438.81M
Enterprise Value
771.91M
1-Year Change
-47.90%
Ranking
Category
Stock Price
$6.56
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $438.81M, a decrease of -38.50%. That is a compound annual growth rate of -9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 438.14M | -36.16% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |